Efficacy and toxicity of docetaxel in elderly men with castrate-resistant metastatic prostate cancer.

被引：1
|
作者：
Shepard, D. R. [1 ]
Weil, A. [1 ]
Garcia, J. A. [1 ]
Dreicer, R. [1 ]
Raghavan, D. [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.4687
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4687
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Elderly patients with metastatic castrate-resistant prostate cancer (mCRPC): Safety and efficacy of docetaxel retreatment
    Gernone, A.
    Pagliarulo, A.
    Calderoni, G.
    Pagliarulo, V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [2] DOCETAXEL IN VERY ELDERLY MEN WITH CASTRATE-RESISTANT PROSTATE CANCER: A RETROSPECTIVE REVIEW
    Wong, H-L
    Lok, S. W.
    Wong, S.
    Parente, P.
    Rosenthal, M.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 45 - 45
  • [3] Management of Docetaxel Failures in Metastatic Castrate-Resistant Prostate Cancer
    Pal, Sumanta K.
    Lewis, Brian
    Sartor, Oliver
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2012, 39 (04) : 583 - +
  • [4] Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial
    Horgan, Anne M.
    Seruga, Bostjan
    Pond, Greg R.
    Alibhai, Shabbir M.
    Amir, Eitan
    De Wit, Ronald
    Eisenberger, Mario A.
    Tannock, Ian F.
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2014, 5 (02) : 119 - 126
  • [5] Retreatment of Men With Metastatic Castrate-Resistant Prostate Cancer With Abiraterone
    Leibowitz-Amit, Raya
    Alimohamed, Nimira
    Vera-Badillo, Francisco E.
    Seah, Jo-An
    Templeton, Arnoud J.
    Knox, Jennifer J.
    Tannock, Ian F.
    Sridhar, Srikala S.
    Joshua, Anthony M.
    [J]. PROSTATE, 2014, 74 (14): : 1462 - 1464
  • [6] Metastatic castrate-resistant prostate cancer
    Schellhammer, Paul
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (01) : 51 - 52
  • [7] Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate-resistant prostate cancer
    Thomson, David
    Charnley, Natalie
    Parikh, Omi
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 (05) : 1040 - 1041
  • [8] Evolution of docetaxel-based therapy for metastatic castrate-resistant prostate cancer
    Cornford, Philip
    [J]. JOURNAL OF CLINICAL UROLOGY, 2010, 3 (06) : 225 - 230
  • [9] Use of bone modifying agents for metastatic castrate-resistant prostate cancer.
    Mitchell, Aaron Philip
    Meza, Akriti Mishra
    Farooki, Azeez
    Panageas, Katherine
    Bach, Peter B.
    Lipitz-Snyderman, Allison
    Morris, Michael J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [10] Patient-reported outcomes with metastatic castrate-resistant prostate cancer.
    Mullally, Jimmy
    Davella, Christopher
    Parikh, Rahul Atul
    Van Londen, G. J.
    Appleman, Leonard Joseph
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (34)
12345